As of June 12, 2025, Hera Med Ltd (HMD.AX) reports a Net Margin of -1507.03%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Hera Med Ltd's Net Margin
Over recent years, Hera Med Ltd's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | -1507.03% |
| 2023-12-31 | -1681.60% |
| 2022-12-31 | -3467.23% |
| 2021-12-31 | -9820.43% |
| 2020-12-31 | -8499.42% |
This slight upward trend highlights how Hera Med Ltd manages its overall profitability and cost control over time.
Comparing Hera Med Ltd's Net Margin to Peers
To better understand Hera Med Ltd's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Hera Med Ltd (HMD.AX) | -1507.03% |
| Elbit Imaging Ltd (EMITF.TA) | 3885.24% |
| Elbit Medical Technologies Ltd (EMTC.TA) | 91.05% |
| Allmed Solutions Ltd (ALMD.TA) | 50.64% |
| Sisram Medical Ltd (1696.HK) | 7.20% |
| Endymed Ltd (ENDY.TA) | 2.43% |
Compared to its competitors, Hera Med Ltd's Net Margin is among the lowest compared to peers, which may indicate challenges in controlling expenses or competitive pricing pressures.